Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor

NCT01403896 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Malignant Lymphoma, Stem Cell Type

Interventions

DRUG: Plerixafor (Mozobil)
DRUG: Plerixafor + G-CSF

Sponsor

Stephen Couban

Collaborators

[object Object]